Netherlands· NL-bc9ae7b6e8b0
Primatour, tabletten
A cinnarizin, kombinationen product containing chloorcyclizinehydrochloride + cinnarizine, registered in Netherlands by Cooper Consumer Health B.V.. The same ATC class is registered in 9 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Cinnarizin, kombinationen is registered in 9 of 19 countries.
Countries holding a registration under ATC N07CA52 (cinnarizin, kombinationen), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Cinnarizin, kombinationen · ATC N07CA52
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of cinnarizin, kombinationen costs, country by country.
Normalised to the WHO defined daily dose (90 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cinnarizin, kombinationen · price per daily dose (90 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.98
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- CHLOORCYCLIZINEHYDROCHLORIDE + CINNARIZINE
- Manufacturer
- Cooper Consumer Health B.V.
- Country
- Netherlands (NL)
- ATC code
- N07CA52
- ATC class
- Cinnarizin, Kombinationen
- Defined daily dose
- 90 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id03178
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N07CA52
Cinnarizin, kombinationen, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9f926128-4a43-4cc4-9d9d-0f5a6c818aa6 GET /v1/drugs/9f926128-4a43-4cc4-9d9d-0f5a6c818aa6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h03178_smpc.pdf",
"strength": null,
"atc_label": "Cinnarizine, Combinations",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg03178",
"excipients": [
"CHINOLINEGEEL (E 104)",
"LACTOSE 1-WATER",
"LEVOMENTHOL",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL",
"POVIDON K 25 (E 1201)",
"SACCHAROIDE NATRIUM X-WATER (E 954)",
"SILICIUMDIOXIDE (E 551)",
"TALK (E 553b)"
],
"substances": [
"CHLOORCYCLIZINEHYDROCHLORIDE",
"CINNARIZINE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h03178.pdf",
"authorised_at": "1990/05/20",
"procedure_number": null,
"dispensing_status": "Uitsluitend apotheek of drogist",
"registration_number": "03178",
"additional_monitoring": "N"
}See everything about cinnarizin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.